ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Heterogeneity in treatment response in patients with HER2 positive breast cancer
The Breast
◽
10.1016/s0960-9776(19)30071-2
◽
2019
◽
Vol 44
◽
pp. S5
Author(s):
L.A. Carey
Keyword(s):
Breast Cancer
◽
Treatment Response
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Related Documents
Cited By
References
Heterogeneity in treatment response in patients with HER2 positive breast cancer
The Breast
◽
10.1016/s0960-9776(19)30068-2
◽
2019
◽
Vol 44
◽
pp. S3-S4
Author(s):
A. Prat
Keyword(s):
Breast Cancer
◽
Treatment Response
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Impact of HER2 heterogeneity on treatment response of early-stage HER2-positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab
Cancer Discovery
◽
10.1158/2159-8290.cd-20-1557
◽
2021
◽
pp. candisc.1557.2020
Author(s):
Otto Metzger Filho
◽
Giuseppe Viale
◽
Shayna Stein
◽
Lorenzo Trippa
◽
Denise A Yardley
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Trial
◽
Treatment Response
◽
Phase Ii
◽
Early Stage
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Her2 Heterogeneity
◽
Positive Breast Cancer
Download Full-text
Abstract P5-10-09: Prediction of Trastuzumab treatment response for HER2-positive breast cancer by microRNA profiling
10.1158/0008-5472.sabcs12-p5-10-09
◽
2012
◽
Author(s):
F Sato
◽
Z Wang
◽
T Ueno
◽
A Myomoto
◽
S Takizawa
◽
...
Keyword(s):
Breast Cancer
◽
Treatment Response
◽
Her2 Positive
◽
Trastuzumab Treatment
◽
Her2 Positive Breast Cancer
◽
Microrna Profiling
◽
Positive Breast Cancer
Download Full-text
Abstract 1937: Development of microRNA-based prediction model of Trastuzumab treatment response for HER2-positive breast cancer using FFPE specimens.
10.1158/1538-7445.am2013-1937
◽
2013
◽
Author(s):
Fumiaki Sato
◽
Zhipeng Wang
◽
Takayuki Ueno
◽
Akira Myomoto
◽
Satoko Takizawa
◽
...
Keyword(s):
Breast Cancer
◽
Prediction Model
◽
Treatment Response
◽
Her2 Positive
◽
Trastuzumab Treatment
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Abstract P5-16-21: The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients
10.1158/1538-7445.sabcs16-p5-16-21
◽
2017
◽
Author(s):
TJ Lillemoe
◽
B Susnik
◽
E Grimm
◽
S-HL Kang
◽
KK Swenson
◽
...
Keyword(s):
Breast Cancer
◽
Neoadjuvant Therapy
◽
Treatment Response
◽
Cancer Patients
◽
Breast Cancer Patients
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Review of treatment strategies for HER2 positive breast cancer and their implementation in a major Swiss hospital
10.1055/s-0040-1710671
◽
2020
◽
Author(s):
F Geissler
◽
M Vetter
◽
A Schoetzau
◽
C Montavon
◽
C Kurzeder
◽
...
Keyword(s):
Breast Cancer
◽
Treatment Strategies
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis
10.26226/morressier.596dfd55d462b80292386fa4
◽
2017
◽
Author(s):
You-Jeong Seo
Keyword(s):
Breast Cancer
◽
Neoadjuvant Chemotherapy
◽
Cancer Patients
◽
Sequential Analysis
◽
Breast Cancer Patients
◽
Her2 Positive
◽
Pik3ca Mutations
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Hypoxia up-regulates ID proteins in Luminal and HER2-positive breast cancer cell lines
10.26226/morressier.5b4709836f4cb30010951ad8
◽
2018
◽
Author(s):
Gloria Peiro Cabrera
Keyword(s):
Breast Cancer
◽
Cell Lines
◽
Cancer Cell
◽
Breast Cancer Cell
◽
Breast Cancer Cell Lines
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Id Proteins
◽
Positive Breast Cancer Cell
◽
Positive Breast Cancer
Download Full-text
FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive breast cancer
Case Medical Research
◽
10.31525/cmr-24bd324
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies
Case Medical Research
◽
10.31525/cmr-24bb59f
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Treatment Option
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
New Treatment
◽
Positive Breast Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close